Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 16;19(5):e0303644.
doi: 10.1371/journal.pone.0303644. eCollection 2024.

Machine learning for the detection and diagnosis of cognitive impairment in Parkinson's Disease: A systematic review

Callum Altham  1 , Huaizhong Zhang  1 , Ella Pereira  1
Affiliations

Machine learning for the detection and diagnosis of cognitive impairment in Parkinson's Disease: A systematic review

Callum Altham et al. PLoS One. .

Abstract

Background: Parkinson's Disease is the second most common neurological disease in over 60s. Cognitive impairment is a major clinical symptom, with risk of severe dysfunction up to 20 years post-diagnosis. Processes for detection and diagnosis of cognitive impairments are not sufficient to predict decline at an early stage for significant impact. Ageing populations, neurologist shortages and subjective interpretations reduce the effectiveness of decisions and diagnoses. Researchers are now utilising machine learning for detection and diagnosis of cognitive impairment based on symptom presentation and clinical investigation. This work aims to provide an overview of published studies applying machine learning to detecting and diagnosing cognitive impairment, evaluate the feasibility of implemented methods, their impacts, and provide suitable recommendations for methods, modalities and outcomes.

Methods: To provide an overview of the machine learning techniques, data sources and modalities used for detection and diagnosis of cognitive impairment in Parkinson's Disease, we conducted a review of studies published on the PubMed, IEEE Xplore, Scopus and ScienceDirect databases. 70 studies were included in this review, with the most relevant information extracted from each. From each study, strategy, modalities, sources, methods and outcomes were extracted.

Results: Literatures demonstrate that machine learning techniques have potential to provide considerable insight into investigation of cognitive impairment in Parkinson's Disease. Our review demonstrates the versatility of machine learning in analysing a wide range of different modalities for the detection and diagnosis of cognitive impairment in Parkinson's Disease, including imaging, EEG, speech and more, yielding notable diagnostic accuracy.

Conclusions: Machine learning based interventions have the potential to glean meaningful insight from data, and may offer non-invasive means of enhancing cognitive impairment assessment, providing clear and formidable potential for implementation of machine learning into clinical practice.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. PRISMA flow diagram of the literature search, screening and extraction procedures for inclusion.
Fig 2
Fig 2. Usage of data modalities across reviewed studies.
Fig 3
Fig 3. Usage of ML techniques across reviewed studies.
Fig 4
Fig 4. Usage of performance metrics across reviewed studies.
Fig 5
Fig 5. Overall risk of bias assessment of studies using PROBAST.
See this image and copyright information in PMC

References

    1. Armstrong MJ, Okun MS. Diagnosis and Treatment of Parkinson Disease: A Review. JAMA. 2020;323(6):548–560. doi: 10.1001/jama.2019.22360 - DOI - PubMed
    1. Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, Mitra T, Frades-Payo B, Tluk S, et al. The Nondeclaration of Nonmotor Symptoms of Parkinson’s Disease to Health Care Professionals: An International Study Using the Nonmotor Symptoms Questionnaire. Movement Disorders. 2010;25(6):704–709. doi: 10.1002/mds.22868 - DOI - PubMed
    1. Parkinson’s UK. The Incidence and Prevalence of Parkinson’s in the UK; 2018.
    1. Tysnes OB, Storstein A. Epidemiology of Parkinson’s Disease. Journal of Neural Transmission. 2017;124(8):901–905. doi: 10.1007/s00702-017-1686-y - DOI - PubMed
    1. Dorsey ER, Elbaz A, Nichols E, Abd-Allah F, Abdelalim A, Adsuar JC, et al. Global, Regional, and National Burden of Parkinson’s Disease, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2018;17(11):939–953. doi: 10.1016/S1474-4422(18)30295-3 - DOI - PMC - PubMed

Publication types